5th Oligonucleotides Analytical Development and CMC
24 24 people viewed this event.
As oligonucleotide therapeutics expand across ASOs, siRNA, gRNA, and increasingly complex conjugates, the field is entering a new phase of clinical and commercial maturity. However, with this progress comes heightened complexity across analytical characterization, impurity profiling, stereochemistry, and control strategy definition, increasing pressure for development teams to deliver robust, scalable, and regulatory-ready CMC packages.
Venue details: The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States
Prices: USD 2699.00 to USD 5297.00
Time: 08:30 to 15:05
Event Organizer: Hanson Wade Conferences Ltd